Modulation of Wnt5a Expression by Periodontopathic Bacteria by Nanbara, Hiromi et al.
Modulation of Wnt5a Expression by Periodontopathic
Bacteria
Hiromi Nanbara
1,2, Nawarat Wara-aswapati
3, Toshiyuki Nagasawa
1¤a, Yasuhiro Yoshida
4*,
Reiko Yashiro
1¤b, Yukiko Bando
1¤c, Hiroaki Kobayashi
1, Janjura Khongcharoensuk
3,
Doosadee Hormdee
3, Waranuch Pitiphat
5, Jason A. Boch
6, Yuichi Izumi
1,2
1Department of Periodontology, Tokyo Medical and Dental University, Tokyo, Japan, 2Global Center of Excellence Program, International Research Center for Molecular
Science in Tooth and Bone Diseases, Tokyo Medical and Dental University, Tokyo, Japan, 3Department of Periodontology, Faculty of Dentistry, Khon Kaen University,
Khon Kaen, Thailand, 4Department of Immunology, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan, 5Department of
Community Dentistry, Faculty of Dentistry, Khon Kaen University, Khon Kaen, Thailand, 6Department of Oral Medicine, Infection and Immunity, Harvard School of Dental
Medicine, Boston, Massachusetts, United States of America
Abstract
Wingless proteins, termed Wnt, are involved in embryonic development, blood cell differentiation, and tumorigenesis. In
mammalian hematopoiesis, Wnt signaling is essential for stem-cell homeostasis and lymphocyte differentiation. Recent
studies have suggested that these molecules are associated with cardiovascular diseases, rheumatoid arthritis, and
osteoarthritis. Furthermore, Wnt5a signaling is essential for the general inflammatory response of human macrophages.
Periodontitis is a chronic inflammatory disease caused by gram-negative periodontopathic bacteria and the resultant host
immune response. Periodontitis is characterized by loss of tooth-supporting structures and alveolar bone resorption. There
have been no previous reports on Wnt5a expression in periodontitis tissue, and only few study reported the molecular
mechanisms of Wnt5a expression in LPS-stimulated monocytic cells. Using RT-PCR, we demonstrated that Wnt5a mRNA
expression was up-regulated in chronic periodontitis tissue as compared to healthy control tissue. P. gingivalis LPS induced
Wnt5a mRNA in the human monocytic cell line THP-1 with a peak at 4 hrs after stimulation. P. gingivalis LPS induced higher
up-regulation of Wnt5a mRNA than E. coli LPS. The LPS receptors TLR2 and TLR4 were equally expressed on the surface of
THP-1 cells. P. gingivalis LPS induced IkBa degradation and was able to increase the NF-kB binding activity to DNA. P.
gingivalis LPS-induced Wnt5a expression was inhibited by NF-kB inhibitors, suggesting NF-kB involvement. Furthermore,
IFN-c synergistically enhanced the P. gingivalis LPS-induced production of Wnt5a. Pharmacological investigation and siRNA
experiments showed that STAT1 was important for P. gingivalis LPS-induced Wnt5a expression. These results suggest that
the modulation of Wnt5a expression by P. gingivalis may play an important role in the periodontal inflammatory process
and serve a target for the development of new therapies.
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Introduction
Wingless, a second chromosome recessive mutation in Drosoph-
ila, was first reported by Sharma and Chopra in 1975 [1]. It was
characterized as a segment polarity gene in Drosophila, which is
essential for embryonic segmentation and patterning [2]. Various
homologs of the Wingless protein, termed Wnt, are involved in
embryonic development, blood cell differentiation during mam-
malian hematopoiesis, and tumorigenesis [3]. In mammalian
hematopoiesis, Wnt signaling is essential for stem-cell homeostasis
[4] and lymphocyte differentiation [5,6].
Of particular interest is Wnt5a, which was first identified in the
mouse [7]. It is secreted by activated antigen-presenting cells and
by inflammatory synoviocytes from rheumatoid arthritis joints [8]
and atherosclerotic lesions [9]. Wnt5a expression is induced by
mycobacterial cell wall components and endotoxin in human
antigen-presenting cells [10], and Wnt5a signaling is essential for
the general inflammatory response of human macrophages during
sepsis [11].
Wnt5a expression is dependent on Toll-like receptor (TLR)
signaling and activation of the central inflammatory regulator NF-
kB in human antigen-presenting cells [10]. Furthermore, inter-
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transducer and activator of transcription 3 (STAT3) signaling
cascade to up-regulate Wnt5a transcription in chronic persistent
inflammation and rheumatoid arthritis [12]. However, little is
known about the expression and modulation of Wnt homologs in
inflammatory settings, such as periodontitis.
Periodontal diseases are infections caused by gram negative
periodontopathic bacteria [13] which colonize on the tooth surface
at or below the gingival margin. In severe cases, these are
accompanied by inflammation of the gingiva and destruction of
periodontal tissues, leading to alveolar bone loss. Periodontopathic
bacteria produce many virulence factors, such as lipopolysaccha-
ride (LPS) and peptidoglycan those induce host immune responses,
including the production of inflammatory cytokines. High levels of
several inflammatory cytokines, such as IL-1a, IL-1b, IL-6,
interferon-c (IFN-c), and tumor necrosis factor a (TNF-a), have
been found in the tissue and gingival crevicular fluid of patients
with advanced periodontitis [14,15]. These inflammatory cyto-
kines are reported to stimulate the production of receptor activator
for nuclear factor kB ligand (RANKL) [16,17], which binds to
receptor activator for nuclear factor kB (RANK) on the surface of
preosteoclasts. This binding stimulates both the differentiation of
osteoclast progenitors and the activity of mature osteoclasts leading
to alveolar bone resorption [18–21].
The purpose of this study was to evaluate the levels of Wnt5a
expression in chronic periodontitis tissue and investigate the
modulation of Wnt5a expression by periodontopathic bacteria.
We show that Wnt5a mRNA was significantly up-regulated in
chronic periodontitis tissue when compared to non-periodontitis
tissue. The expression of Wnt5a was dependent on the NF-kB
pathway and was partly mediated by the STAT1 signaling
pathway in response to P. gingivalis LPS/IFN-c in the human
monocytic cell line THP-1. This result suggests that the
modulation of Wnt5a expression by P. gingivalis may play an
important role in the periodontal inflammatory process.
Results
Wnt5a was significantly up-regulated in chronic
periodontitis tissues
Wnt5a signaling is known to be essential for the general
inflammatory response [11] and it is secreted in chronic inflamed
site such as inflammatory synoviocytes [8], the atherosclerotic
lesions [9], and the serum and bone marrow of patients with severe
sepsis [11]. Table 1 summarizes the characteristics of the study
subjects and sampling sites. Subjects in the periodontitis group
were significantly older, and had higher mean PD, mean CAL and
proportion of BOP-positive sites as compared with the control
group. Production of Wnt5a mRNA was detected in all gingival
tissue samples (Fig. 1). The mean relative mRNA level of Wnt5a
was significantly higher in the periodontitis group (1.4460.26)
than in the control group (1.0060.22; p,0.001). Additional
regression analysis controlling for the effect of age confirmed these
results that chronic periodontitis was associated with increased
mRNA levels of Wnt5a (p,0.001).
Wnt5a mRNA was expressed by the human monocytic
cell line THP-1 in response to P. gingivalis LPS
The human gingival fibroblast cell line HGF-1 and the human
monocytic cell line THP-1 were stimulated with A. actinomycetemco-
mitans sonicated extract, P. gingivalis sonicated extract, P. gingivalis
LPS, or TNF-a for 4 hrs. Our results showed that the expression
of Wnt5a mRNA in HGF-1 cells was constant in response to
different treatments (Fig. 2A). However, in THP-1 cells, Wnt5a
mRNA was strongly induced by P. gingivalis LPS but was only
slightly increased by P. gingivalis sonicated extracts or a high
concentration of TNF-a. Live P. gingivalis also significantly
increased the expression of Wnt5a mRNA in THP-1 (Fig. 2E).
When THP-1 cells were stimulated with various concentrations of
P. gingivalis LPS or E. coli LPS (Fig. 2C), the maximum Wnt5a
mRNA expression occurred after stimulation with 1 mg/ml of P.
gingivalis LPS. P. gingivalis LPS could induce more potent Wnt5a
mRNA expression than E. coli LPS. When THP-1 cells were
Figure 1. The levels of Wnt5a mRNA were significantly up-
regulated in chronic periodontitis tissues. Upper panel; Total RNA
was extracted from periodontitis tissues, and the expression of Wnt5a
mRNA was detected by RT-PCR. PCR products were electrophoresed on
a 1.5% agarose gel and visualized by UV illumination. b-actin served as
the internal control. Results are representative of five patients (right
panel). Lower panel; The relative mRNA levels of Wnt5a. The horizontal
line within each box represents the median expression level in each
group.
doi:10.1371/journal.pone.0034434.g001
Table 1. Characteristics of the Study Subjects.
Charactereistic Comparison group
Control group Periodontitis group p-value*
(n=14) (n=13)
Age in years 31.0613.1 43.5613.0 0.02
(mean 6 SD)
Female 12 (85.7) 10 (76.9) 0.65
n( % )
Probing depth** 2.060.9 9.561.9 ,0.001
(mm; mean 6 SD)
Clinical attachment
level**
0.860.7 10.562.6 ,0.001
(mm; mean 6 SD)
Bleeding on probing* 3 (21.4) 13 (100) ,0.001
n( % )
*Mann-Whitney U test for continuous data, and Fisher’s exact test for binary
data.
**Measured at the sampling sites.
doi:10.1371/journal.pone.0034434.t001
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24 hrs, the maximum expression of Wnt5a mRNA occurred at
4 hrs after stimulation (Fig. 2B). Flow cytometry demonstrated
that TLR2 and TLR4 were equally expressed on the surface of
THP-1 cells stimulated by P. gingivalis LPS and E. coli LPS,
suggesting that the expression of these receptors were not changed
by the stimulation (Fig. 2D). P. gingivalis LPS-induced Wnt5a
mRNA was significantly reduced by either TLR2 siRNA or TLR4
siRNA (Fig. 2H), suggesting that P. gingivalis LPS used in this study
utilized both TLR2 and TLR4.
In primary human gingival fibroblasts (HGF), the expression of
Wnt5a mRNA was rather constant after stimulation with P.
gingivalis LPS (Fig. 2F). On the contrary, in primary monocytes,
Wnt5a mRNA expression was significantly increased by P.
gingivalis LPS and was reduced by using NF-kB inhibitor MG132
(Fig. 2G). These results suggest that monocytes, but not HGF, play
an important role in Wnt5a up-regulation at inflamed site.
The P. gingivalis-LPS induced Wnt5a expression is
dependent upon NF-kB signaling
A recent study showed that Wnt5a expression is dependent on
the activation of the central inflammatory regulator NF-kB [10].
We examined the degradation of IkBa in THP-1 cells stimulated
with P. gingivalis LPS. After 30 mins or 4 hrs, whole cell lysates
were subjected to Western blot. In unstimulated THP-1 cells, IkBa
was abundant. In contrast, stimulation with P. gingivalis LPS
markedly reduced the cytosolic level of IkBa (Fig. 3A). To
examine P. gingivalis LPS-induced NF-kB activity, THP-1 cells
were transfected with a luciferase reporter plasmid containing the
NF-kB binding site for 18 hrs. After treatment with P. gingivalis
LPS, the luciferase activity was measured with a luminometer. P.
gingivalis LPS-induced NF-kB activity was significantly upregulated
in THP-1 cells (Fig. 3B). Further, the ability of NF-kB to bind to
DNA was analyzed by electrophoretic mobility shift assay (EMSA).
The [c-
32P]-labeled probe, which contained the NF-kB binding
consensus sequence, was incubated with the nuclear extract of
THP-1 cells stimulated with P. gingivalis LPS for 40 minutes.
Protein-DNA complex bands (Fig. 3C, lower arrow) were super-
shifted by the addition of anti-p65 antibody (Fig. 3C, upper
arrow). This result suggests that P. gingivalis LPS is able to increase
the NF-kB binding activity to DNA.
The addition of wedelolactone or IKK inhibitor VII, which act
as selective irreversible inhibitors of IKKa or IKKb kinase
activities, inhibited P. gingivalis LPS-induced Wnt5a mRNA in a
dose-dependent manner expression (Fig. 4A, 4B). Moreover, the
effect of an expression vector for a dominant-negative form of
IkBa was investigated. The expression of P. gingivalis LPS-induced
Wnt5a mRNA was inhibited by transfection with a dominant-
negative IkBa plasmid (Fig. 4C). Taken together, our results
indicate that the induction of Wnt5a mRNA expression by P.
gingivalis LPS is dependent upon NF-kB signaling.
The induction of Wnt5a is partly mediated via the JAK/
STAT signaling pathway
Tandem STAT3-binding sites in the Wnt5a gene have been
identified [22]. We examined the role of the JAK/STAT pathway
in the regulation of Wnt5a mRNA expression. AG490 (JAK/
STAT inhibitor), fludarabine (STAT1 inhibitor), and STA21
(STAT3 inhibitor) were used to inhibit the JAK/STAT pathway
1 hr prior to P. gingivalis LPS stimulation. Pretreatment with either
AG490 or fludarabine significantly decreased Wnt5a mRNA
expression in THP-1 cells in a dose-dependent manner (Fig. 5A,
B). Additionally, STAT1 siRNA was able to suppress the induction
of Wnt5a by P. gingivalis LPS as compared to control siRNA
(Fig. 5C). However, the P. gingivalis LPS-induced Wnt5a mRNA
expression was augmented by a STAT3 inhibitor, STA21
(Fig. 5D). Our results suggest that STAT1 positively regulated
induction of Wnt5a by P. gingivalis LPS.
Wnt5a mRNA expression was increased by co-stimulation
with P. gingivalis LPS and IFN-c
To investigate the role of the JAK/STAT pathway in detail, we
examined the expression of Wnt5a mRNA after co-stimulation
with P. gingivalis LPS and either IL-6, IFN-b, or IFN-c. IL-6, IFN-
b, or IFN-c alone did not elicit the induction of Wnt5a mRNA
when compared to the control. Wnt5a mRNA levels were up-
regulated in the presence of P. gingivalis LPS alone. Furthermore,
P. gingivalis LPS together with IFN-c synergistically activated
Wnt5a mRNA expression (Fig. 6A).
IFN-c induces the phosphorylation of STAT1, which forms
STAT1 homodimers. The effects of an expression vector for wild-
type STAT1 on Wnt5a expression were investigated. After
transfection, THP-1 cells were co-stimulated with P. gingivalis
LPS and IFN-c. The expression of Wnt5a mRNA was markedly
increased by transfection with a wild-type STAT1 expression
plasmid (Fig. 6B). Additionally, STAT1 siRNA significantly
suppressed the Wnt5a mRNA expression induced by P. gingivalis
LPS and IFN-c (Fig. 6C). These results suggest that the induction
of Wnt5a mRNA by co-stimulation with P. gingivalis LPS and IFN-
c is partly mediated via STAT1 signaling.
Discussion
In this study, we investigated the levels of Wnt5a expression in
chronic periodontitis tissues, and the modulation of Wnt5a
expression by periodontopathic bacteria. Wnt5a mRNA was
significantly up-regulated in chronic periodontitis tissues as
compared to healthy control tissues. Chronic inflammatory
periodontitis tissue comprises of epithelial cells, gingival fibroblasts
and inflammatory cells including PMNs, monocytes and macro-
phages. The expression of Wnt5a was dependent upon the NF-kB
signaling pathway and was partly mediated by the STAT1
signaling pathway in response to P. gingivalis LPS/IFN-c in the
human monocytic cell line THP-1.
Wnt5a is secreted by activated antigen-presenting cells [8,10,11]
and said to be induced by M. tuberculosis, M. avium, S. aureus or S.
typhimurium [10,23]. The expression of Wnt5a mRNA in response
to periodontopathic bacterial stimuli was also observed in
periodontal tissue cells. Whereas the expression of Wnt5a was
constant in response to different treatments in HGF-1 cells, it was
specifically up-regulated by P. gingivalis LPS and was slightly
increased by P. gingivalis sonicated extracts in the human
monocytic cell line THP-1. Sonicated extract of P. gingivalis
comprises of various components including protein, lipid, LPS and
other factors, which have different properties to stimulate host
immune responses. But P. gingivalis LPS from InvivoGen is ultra-
pure LPS (according to the manufacturer) and thus possesses a
high concentration of LPS. In our study, primary cells including
monocytes and gingival fibroblasts responded to P. gingivalis LPS in
a similar manner to the cell lines (THP-1 and HGF-1).
P. gingivalis is considered to be an important member of the
periodontopathic bacteria involved in periodontal disease [24,25]
leading to inflammation and destruction of alveolar bone and the
supporting connective tissue surrounding teeth. P. gingivalis is a
gram-negative obligate anaerobic rod bacterium that has virulence
factors such as LPS [24]. Although TLR4 has been reported to
function as an LPS signaling receptor, P. gingivalis LPS is less
Wnt5a Induction by Periodontopathic Bacteria
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Ao fP. gingivalis differs both structurally and functionally from E.
coli lipid A [24], and P. gingivalis LPS utilizes either TLR2 and
TLR4 to mediate inflammatory signaling [27]. Indeed, in this
study, the expression of Wnt5a mRNA was down-regulated by
Figure 2. Wnt5a was specifically up-regulated in THP-1 cells by P. gingivalis LPS. (A) HGF-1 and THP-1 cells were stimulated with A.
actinomycetemcomitans sonicated extract, P. gingivalis sonicated extract, P. gingivalis LPS, and TNF-a for 4 hrs, and the expression of Wnt5a mRNA
was detected by RT-PCR. PCR products were electrophoresed on a 1.5% agarose gel and visualized by UV illumination. GAPDH served as the internal
control. (B) THP-1 cells were stimulated with 1 mg/ml of P. gingivalis LPS for 0.5, 2, 4, 12, or 24 hrs, and the expression of Wnt5a mRNA was detected
by real-time PCR. Relative expression levels of Wnt5a are shown. (C) THP-1 cells were stimulated with 0.01–10 mg/ml of P. gingivalis LPS (black bars) or
E. coli LPS (gray bars) for 4 hrs, and then the expression of Wnt5a mRNA was detected by real-time PCR. Relative expression levels of Wnt5a are
presented. (D) THP-1 cells were stimulated with E. coli 055:B5 LPS (middle and right upper panels) or P. gingivalis LPS (middle and right lower panels)
for 30 min or 4 hrs, and then the expression of surface TLR2 and TLR4 protein was determined by flow cytometry. Left upper panel shows no-staining
condition, and left lower panel shows un-stimulated condition with staining. (E, F, G, H) The expression of Wnt5a mRNA was detected by real-time
PCR. Relative expression levels of Wnt5a mRNA are shown. (E) THP-1 cells were stimulated with 10
4–10
7 cells/ml of live P. gingivalis for 4 hrs. (F, G)
Primary human gingival fibroblasts (HGF) and human monocytes were stimulated with 1 mg/ml of P. gingivalis LPS for 4 hrs. Monocytes were
pretreated with the NF-kB inhibitor MG132 for 1 hr. Here we describe typical dates of three samples. (H) THP-1 cells were stimulated with P. gingivalis
LPS for 4 hrs after being transfected with TLR2 siRNA, TLR4 siRNA or control siRNA for 72 hrs. *p,0.05.
doi:10.1371/journal.pone.0034434.g002
Figure 3. Induction of Wnt5a expression is NF-kB dependent.
(A) THP-1 cells were stimulated with E. coli LPS or P. gingivalis LPS for
30 mins or 4 hrs. Whole cell extracts were prepared and analyzed by
Western blot by using antibodies against IkBa. b-actin served as the
protein loading control. (B) THP-1 cells were stimulated with P.
gingivalis LPS for 4 hrs after being transfected with NF-kB reporter
plasmid for 12 hrs, and the transcription activity was assessed by
luminometer. The activity is represented by the relative luciferase
activity. (C) Nuclear extracts were prepared and EMSA was performed
with c
32P-labeled oligonucleotides representing the NF-kB consensus
sequence as a probe. Anti-p65 antibody was used for supershift assays.
The lower arrow shows the DNA-protein complex, and the upper arrow
shows the supershifted band. *p,0.05.
doi:10.1371/journal.pone.0034434.g003
Figure 4. P. gingivalis LPS-induced Wnt5a expression was
inhibited by wedelolactone or dnIkBa. (A, B) THP-1 cells were
pre-treated with the IKK inhibitor wedelolactone or the IKK inhibitor VII
for 1 hr. The expression of Wnt5a mRNA was detected by real-time PCR.
Relative expression levels of Wnt5a are presented. DMSO is a solvent
control for both inhibitors. (C) THP-1 cells were transfected with a
dominant-negative form of IkBa (dnIkBa) or the parent plasmid (pUSE)
for 12 hrs. Fold induction of Wnt5a mRNA expression is shown.
*p,0.05.
doi:10.1371/journal.pone.0034434.g004
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dependent. (A–D) The expression of Wnt5a mRNA was detected by
real-time PCR. Relative expression levels of Wnt5a are presented. (A, B)
THP-1 cells were pre-treated with AG490 (A) or fludarabine (B) for 1 hr
and then stimulated with P. gingivalis LPS for 4 hrs. DMSO is a solvent
control for both inhibitors. (C) THP-1 cells were stimulated with P.
gingivalis LPS for 4 hrs after transfection with STAT1 siRNA or control
siRNA for 18 hrs. (D) THP-1 cells were pre-treated with STA21 for 1 hr
and stimulated with P. gingivalis LPS for 4 hrs. *p,0.05.
doi:10.1371/journal.pone.0034434.g005
Figure 6. The expression of Wnt5a was increased by co-
stimulation with P. gingivalis LPS and IFN-c. (A–C) The expression
of Wnt5a mRNA was detected by real-time PCR. Relative expression
levels of Wnt5a are presented. (A) THP-1 cells were stimulated with
10 ng/ml of IL-6, 10 ng/ml of IFN-b or 10 ng/ml of IFN-c with or without
P. gingivalis LPS for 4 hrs. (B) THP-1 cells were transfected with wild-
type STAT1 expression vector or parent plasmid 12 hrs prior to
stimulation with P. gingivalis LPS/IFN-c for 4 hrs. (C) THP-1 cells were
stimulated with P. gingivalis LPS for 4 hrs after being transfected with
STAT1 siRNA or control siRNA for 18 hrs. *p,0.05.
doi:10.1371/journal.pone.0034434.g006
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activates a variety of intracellular signaling pathways that
ultimately activate the transcriptional factor NF-kB [28]. In this
study, the expression of Wnt5a mRNA induced by P. gingivalis LPS
was higher than the expression induced by E. coli LPS. However,
the expression of TLR2 and TLR4 receptors on the surface of
THP-1 cells was not changed after stimulation with P. gingivalis
LPS or E. coli LPS. These results suggest that the difference in
Wnt5a mRNA expression level between P. gingivalis LPS and E. coli
LPS is not dependent upon the expression of TLR. Generally,
activated NF-kB induces IkBa de novo, then IkBa will be
comparable level to no stimulation as seen in E. coli LPS (Fig. 3A).
It is not clear but there might be some involvement in strong
induction of Wnt5a by P. gingivalis LPS in comparison with E. coli
LPS. In addition, P. gingivalis LPS is said to induce lower IL-10
than E. coli LPS in dendritic cells generated from human
peripheral monocytes [29] suggesting that down-regulation of
Wnt5a by P. gingivalis LPS-induced IL-10 may be weaker than E.
coli LPS.
In this study, we found that AG490 and Fludarabine, but not
STA21, were capable of suppressing P. gingivalis LPS-mediated
Wnt5a up-regulation in THP-1 cells. Fludarabine is used in the
treatment of various hematological malignancies, particularly B-
cell chronic lymphocytic leukemia. It has also been shown that
Fludarabine reduces STAT1 phosphorylation and suppress
STAT1 protein and transcript levels [30,31]. On the other hand,
the expression of Wnt5a was significantly augmented by
pretreatment with STA21 compared to P. gingivalis LPS alone.
This suggests that STAT3 plays some role in the expression of
Wnt5a.
Wnt5a might be up-regulated by P. gingivalis LPS and IFN-c via
NF-kB and STAT1 pathways, and induce various cellular
functions. Wnt5a activates the non-canonical pathway which
results in up-regulation of inflammatory cytokines such as IL-6, IL-
8, IL-1b and MIP-1b [11] and these cytokines ultimately induce
bone resorption [16,17]. Moreover, increased levels of Wnt5a and
cytokines may affect other mono nuclear cells including T-cells
leading sustained inflammation [10] and affect surrounding
resident tissue cells, including vascular smooth muscle cells and
endothelial cells [32–34]. Taken together, Wnt5a may play an
important role in periodontal inflammation.
Inflammatory reactions are regulated by cytokines. IFN-c
orchestrates immune response cross-talk with other cytokines or
extracellular stimuli such as LPS. For example, pro-inflammatory
genes such as inducible nitric-oxide synthase [35,36] and
intercellular adhesion molecule 1 [37] were induced by co-
stimulation with IFN-c and LPS. Here, we also show a synergistic
effect of P. gingivalis LPS and IFN-c but not IL-6 or type I IFN
(IFN-b) on Wnt5a expression in the human monocytic cell line
THP-1. These synergistic effects might be mediated by transcrip-
tion factors such as NF-kB and STAT1, although additional
experiments are needed. Ohmori et al. demonstrated a synergistic
effect of NF-kB and STAT1 on iNOS gene induction in Raw264
cells that was activated by LPS or IFN-a, respectively [36]. On the
contrary, in our system, we could not observe a synergistic effect of
LPS and IFN-a on Wnt5a induction, suggesting that the autocrine
loop of LPS-induced IFN-a is not involved in Wnt5a induction.
Previously, we reported that NF-kB and STAT3 co-operative role
on several genes [38]. In this paper, we used a pharmacological
approach to examine STAT3 involvement in Wnt5a induction.
Unexpectedly, an inhibitor of STAT3 increased the Wnt5a
mRNA level. Furthermore, STAT3 phosphorylation was not
observed until 4 hrs after stimulation in THP-1 cells (data not
shown). These results suggest that STAT3 does not positively
regulate Wnt5a expression, while it is still unclear if STAT3 plays
a role as a negative regulator. The relationship between Wnt5a
and STAT3 is cell specific [22,39]. We conclude that Wnt5a gene
expression is regulated by NF-kB and STAT1 with different
regulatory mechanisms.
Materials and Methods
Study population, clinical examination, and sampling of
gingival tissue
The Khon Kaen University review committee approved the
protocol for human subjects. Twenty-seven subjects were enrolled
in this study. All subjects had at least 10 natural teeth and were
systemically healthy. After having signed informed consent forms,
samples of gingival tissues were obtained from 14 periodontally
healthy individuals (control group) and 13 patients with general-
ized moderate to severe chronic periodontitis [40] during
extraction of teeth. Each subject had at least one tooth which
was planned for extraction due to severe periodontal destruction
and inflammation (chronic periodontitis patient) or for orthodontic
treatment or crown lengthening procedure (control subject). The
PD, CAL, and bleeding on probing (BOP) of the sampling sites
were evaluated using a periodontal probe (Hu-Friedy, Leimen,
Germany).
Human monocyte and human gingival fibroblast
The Tokyo Medical and Dental University review committee
approved the protocol for human subjects. After acquiring
informed consent, peripheral blood was obtained by venipuncture
from 3 healthy volunteers. Peripheral blood mononuclear cells
(PBMCs) were isolated by density-gradient centrifugation using
Lymphoprep (Axis-Shield, Oslo, Norway). Monocytes were
purified by using the MACS Monocyte Isolation Kit II (Miltenyi
Biotec, Bergisch Gladbach, Germany). Human gingival fibroblasts
(HGF) were isolated from three systemically healthy patients with
periodontitis. Three healthy gingival samples were collected
during flap surgery. The washed explants were placed in a sterile
dish and minced into smaller pieces with a sterile scalpel blade.
Attempts were made to remove the epithelium and leave only
connective tissue. Fibroblastic cells were allowed to grow out from
the explant at 37uC in a humidified atmosphere with 5% CO2 in
the air until they formed a confluent layer, at which point they
were subcultured. Cells subcultured to the fifth passage.
Cell culture
The human monocytic cell line THP-1 and the human gingival
fibroblast cell line HGF-1 were obtained from the American Type
Culture Collection (ATCC, Rockville, MD). THP-1 cells and
HGF-1 cells were cultured in RPMI 1640 (Lonza, Basel,
Switzerland) and DMEM (ATCC) supplemented with 10% heat-
inactivated fetal bovine serum (FBS, Hyclone, Logan, UT) and 1%
antibiotics (100 U/ml of penicillin and 100 mg/ml of streptomy-
cin). All cells were grown at 37uC in a humid incubator with 5%
CO2.
Bacteria, reagents, and antibodies
Aggregatibacter actinomycetemcomitans ATCC 43718 and Porphyromo-
nas gingivalis 381 were cultured, and sonicated extracts were
prepared as described previously [41]. Live P. gingivalis 381 (kindly
gifted from Dr. Takeuchi), P. gingivalis LPS (InvivoGen, San Diego,
CA), E. coli 055:B5 LPS (Sigma, Taufkirchen, Germany), IL-6,
IFN-b, and IFN-c (R&D systems, Minneapolis, MN) were
purchased from the respective companies. Unless otherwise stated,
A. actinomycetemcomitans and P. gingivalis were added to cell cultures
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concentration of 2 ng/ml or 10 ng/ml. IL-6, IFN-b, and IFN-c
were added at a final concentration of 10 ng/ml.
In some experiments, specific signal transduction inhibitors for
JAK/STAT (AG490, Calbiochem, San Diego, CA), STAT1
(fludarabine, WAKO, Osaka, Japan), STAT3 (STA21, Santa
Cruz Biotechnology, Santa Cruz, CA), NF-kB (MG132, Calbio-
chem) and IKK (wedelolactone, IKK inhibitor VII, Calbiochem)
were added 1 hr prior to stimulation with P. gingivalis LPS. When
necessary, inhibitors were diluted in DMSO or ethanol. Cell
viability was measured by using the Cell Counting Kit-8
(DOJINDO, Kumamoto, Japan). To all unstimulated and control
samples, equal amounts of inhibitor solvent were added. Neither
DMSO nor ethanol at the concentrations used to prepare
inhibitors affected THP-1 cell viability (data not shown).
Antibody for inhibitor kBa (IkBa, sc-371) was purchased from
Santa Cruz Biotechnology (Santa Cruz). Anti-b-actin antibody
(A5441) was generated by Sigma. HRP-conjugated anti-rabbit
IgG (#458) and HRP-conjugated anti-mouse IgG (NA931VS)
were purchased from MBL (Nagoya, Japan) and Amersham
Pharmacia Bioscience (Buckinghamshire, U.K).
RNA extraction and RT-PCR
Total RNA from gingival tissues and cells was isolated by using
an RNeasy Mini kit (Qiagen) according to the manufacturer’s
instructions, and concentrations were measured by spectropho-
tometry. RNA quality was assessed by measuring the ratio of
absorbance at 260 nm to the absorbance at 280 nm. Reverse
transcription-polymerase chain reaction (RT-PCR) was performed
with an RT-PCR kit (One-step RT-PCR kit, Qiagen) using a
thermal cycler (GeneAmpH PCR system 2400, Perkin Elmer,
Roche, NJ, USA). Specific oligonucleotides were synthesized
(Qiagen) based on the published sequences of Wnt5a, forward 59
TTT TTC TCC TTC GCC CAG GTT GT 39, reverse 59 GGC
TCA TGG CGT TCA CCA C 39; b-actin, forward 59 TGA CGG
GGT CAC CCA CAC TGT GCC CAT CTA 39, reverse, 59
CTA GAA GCA TTT GCG GTG GAC GAT GGA GGG-39;
and GAPDH forward, 59 ACC ACA GTC CAT GCC ATC AC
39, reverse 59 ACC ACC CTG TTG CTG TA 39. Real-time RT-
PCR was performed with a QuantiTect PrimerAssay and SYBR
Green PCR Master Mix (Qiagen) with LightCycler technology
(Roche Diagnosis, Mannheim, Germany) and StepOne (Applied
Biosystems, Foster City, CA). Wnt5a mRNA expression was
displayed as relative expression normalized to b-actin or GAPDH.
Flow cytometry
Cell surface expression of TLR2 and TLR4 on THP-1 cells was
determined by flow cytometry. After washing, cells were stained
with FITC anti-mouse/human TLR2 (Abcam, Cambridge, UK)
and PE anti-human TLR4 (eBioscience, San Diego, CA). Data
were analyzed by the FACS Calibur (Becton Dickinson, San Jose,
CA).
Western blotting
THP-1 cells were lysed with RIPA lysis buffer (1% Nonidet P-
40, 0.5% sodium deoxycholate, 0.1% SDS, and protease inhibitor
cocktail) for preparation of whole cell extracts. Equivalent amounts
of protein (10 mg) were resolved on SDS-PAGE gels, transferred
and immobilized on nitrocellulose membranes (Amersham, Little
Chalfont, UK), and probed with appropriate primary and
secondary antibodies.
Transfection and luciferase assay
THP-1 cells were transfected with the transfection reagent
Lipofectamine
TM2000 (Invitrogen, Carlsbad, CA) at 3 mlo f
reagent per one mg of DNA as previously reported [38]. IkB
dominant-negative vectors (S32A, S36A double mutant) and
pUSE control vectors were obtained from Upstate Biotechnology
(Lake Placid, NY). STAT1 vectors were constructed by inserting
PCR-amplified STAT1 cDNA fragments into the pcDNA3.1
expression vector (Invitrogen). All plasmids for transfections were
prepared by means of the EndoFree Plasmid Maxi Kit (Qiagen).
NF-kB luciferase reporter construct [38] and expression vectors
were added to 90% confluent cells in 24-well culture plates. At
18 hrs after transfection, cells were stimulated with P. gingivalis
LPS. After an additional 4 hrs of incubation, the cells were lysed
with Passive Lysis Buffer (Promega, Madison, WI). Luciferase
activity was measured by using a luminescencer-JNR-II.
siRNA transfection
RNA interference for STAT1 (Cell Signaling, Danvers, MA),
TLR2, TLR4 (Santa Cruz) and negative control siRNA (Cell
Signaling) were used. STAT1 siRNA (Cell Signaling, Danvers,
MA) and negative control siRNA (Cell Signaling) were used. THP-
1 cells were transfected with Lipofectamine
TM RNAiMAX
Reagent (Invitrogen) according to the manufacturer’s protocol
and incubated for 18 hrs. A 42% knockdown of STAT1 mRNA
was measured. Following transfection, THP-1 cells were stimulat-
ed with P. gingivalis LPS for 4 hrs.
Electrophoretic mobility-shift assay (EMSA)
EMSA was performed as described previously [38]. Cells were
lysed with NucBuster protein Extraction Kit according to the
manufacturer’s instructions (Novagen, Darmstadt, Germany).
Murine NF-kB oligonucleotide, 59-AGTTGAGGGGACTTTCC-
CAGGC-39, was purchased from Promega. Ten mg of extract was
pre-incubated for 20 min at room temperature in 15 ml of buffer
(10 mM Tris–HCl pH 7.5, 1 mM EDTA, 1 mM b-mercaptoeth-
anol, 4% glycerol, and 40 mM NaCl) containing 1 mg of poly (dI-
dC) and the oligonucleotide labeled with T4 polynucleotide kinase
(New England Biolabs, Beverly, MA) and [c-
32P]ATP (111 TBq
mmol-1, Amersham Pharmacia Biotech, Little Chalfont, UK).
Protein–DNA complexes were resolved on 4% TBE polyacryl-
amide gels and analyzed with a specific antibody.
Statistical analysis
Data are represented as means 6 SD for replicate experiments.
The Mann-Whitney U test was used to compare the Wnt5a/b-
actin ratios between periodontitis tissue and non-periodontitis
tissue. Data were subjected to one-way analysis of variance
(ANOVA) using StatView. Fisher’s prospected least significance
test was used for the post hoc comparison of specific groups. A
value of p,0.05 was considered statistically significant.
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